Simeprevir

Results: 32



#Item
1Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Add to Reading List

Source URL: www.hepatitis-schweiz.ch

Language: English - Date: 2016-02-01 04:42:51
2NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
3--------------------------------CONTRAINDICATIONS-----------------------------­ EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

--------------------------------CONTRAINDICATIONS-----------------------------­ EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2016-06-28 12:26:37
4Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Add to Reading List

Source URL: sasl.unibas.ch

Language: English - Date: 2016-01-13 10:08:24
5Guidelines EASL Recommendations on Treatment of Hepatitis C 2015 European Association for the Study of the Liver ⇑ Introduction

Guidelines EASL Recommendations on Treatment of Hepatitis C 2015 European Association for the Study of the Liver ⇑ Introduction

Add to Reading List

Source URL: www.easl.eu

Language: English - Date: 2015-09-08 13:26:17
6TF_AITemplate_210x280_RZ.indd

TF_AITemplate_210x280_RZ.indd

Add to Reading List

Source URL: www.pcsg.org.uk

Language: English - Date: 2016-08-01 07:11:56
7NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni)

NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni)

Add to Reading List

Source URL: www.janusinfo.se

Language: Swedish - Date: 2014-12-22 02:37:28
    8Horizon Scanning Centre March 2015 Simeprevir in combination with sofosbuvir (with or without ribavirin) for chronic hepatitis C

    Horizon Scanning Centre March 2015 Simeprevir in combination with sofosbuvir (with or without ribavirin) for chronic hepatitis C

    Add to Reading List

    Source URL: www.hsc.nihr.ac.uk

    Language: English
    9Interim Clinical Commissioning Policy Statement: Simeprevir for treating Genotype 1 Chronic Hepatitis C Reference: NHS England A02/PS/c

    Interim Clinical Commissioning Policy Statement: Simeprevir for treating Genotype 1 Chronic Hepatitis C Reference: NHS England A02/PS/c

    Add to Reading List

    Source URL: www.england.nhs.uk

    Language: English - Date: 2015-01-14 05:24:48
    10® OLYSIO Capsules simeprevir Consumer Medicine Information

    ® OLYSIO Capsules simeprevir Consumer Medicine Information

    Add to Reading List

    Source URL: www.janssen.com.au

    Language: English - Date: 2014-07-23 21:37:04